Aims: To investigate the numbers, morphology, and lineage assignment of Ki-67 positive cells in peripheral blood from normal subjects. Methods: Single and double immunoenzymatic staining procedures, immunoperoxidase, and immunoalkaline phosphatase were used with Ki-67, a monoclonal antibody that recognises a nuclear antigen present in proliferating cells, with markers expressed in B and T lymphocytes and monocytes. Results: In the five healthy donors 2-1% (range 1P6-3-7%) cells of the blood mononuclear fraction and 2-7% (range 2-3-3-9%) lymphocytes were Ki-67 positive. Of these, 88% (range 85-90%) were small cells and 12% (range 10-15%) were medium sized. 
scribed is useful for the simultaneous detection of nuclear and cytoplasmic antigens. The demonstration that a proportion of normal blood lymphocytes are in cell cycle raises the issue of whether immunophenotypic analysis of Ki-67 positive cells in haemopoietic malignancies with peripheral blood disease should be carried out to define more precisely the proportion of normal and neoplastic cells in cycle.
The proportion of cells in cycle in normal and pathological tissues used to be estimated by the number of mitotic figures seen on histological examination. New techniques have permitted more precise characterisation of the dynamics of this process. Methods widely used include 3H thymidine uptake into the cellular DNA, measured by autoradiography or scintillation counting,1 assessment of the DNA content with propidium iodide or acridine orange by cytofluorometry,23 and the reactivity with autoantibodies from patients with systemic lupus erythematosus or leukaemia which detect nuclear antigens expressed in proliferating cells.45 Monoclonal antibodies against the transferring receptor (OKT9), 5-bromo-2' deoxyuridine, and the proliferating cell nuclear antigen (PCNA), have also been used.' Among the antibodies that detect cycling cells, Ki-67 seems to be the most widely used. Ki-67 is a mouse antibody raised against the human L428 Hodgkin's disease cell line that recognises a nuclear antigen expressed in proliferating cells but not in resting cells.9 This antigen is expressed throughout the GI, S, G2 and M phases of the cell cycle but is absent in GO phase.'0
Because there is little information on the reactivity with Ki-67 in non-neoplastic conditions, we investigated the numbers, morphology, and lineage assignment of Ki-67 positive cells in peripheral blood from normal subjects using single and double immunoenzymatic staining procedures.
Methods
Peripheral blood, taken into heparin, was obtained from five healthy adults, aged 24 peroxide. Cells were counterstained with haematoxylin S 'Gurr' (Merck) for one minute. All the incubations were performed at room temperature. Normal mouse serum in place of the first layer was used as a negative control.
DOUBLE IMMUNOCYTOCHEMICAL STAINING
Ki-67 and anti-CD3 For the simultaneous detection of Ki-67 and CD3, sequential immunoenzymatic staining was applied that combined the immunoperoxidase sandwich with the immunoalkaline phosphatase technique2 13 (fig 1) . After staining with Ki-67 the cytospins were washed for five minutes in TRIS-buffered saline (TBS) and subsequently incubated with the UCHT1 (diluted 1 in 10 in TBS) for 30 minutes at room temperature. This was followed by a 30 minute incubation with R anti-M (diluted 1 in 20 in TBS with 5% normal human AB serum) and after a further wash with the APAAP complexes (diluted 1 in 60 in TBS) for 45 minutes. The developing medium for the alkaline phosphatase containing Fast Red salt as substrate. '3 Slides were counterstained with haematoxylin for one minute and mounted with Glycergel (Dakopatts). Normal mouse serum replaced UCHTl in the negative control.
Ki-67 and anti-light chains Ig Polyclonal antibodies to human light chains R anti-K and R anti-A were used in an indirect immunoenzymatic sandwich before or simultaneously with the immunoperoxidase staining for Ki-67 (fig 2) . In the sequential procedure cytospins were incubated with the primary polyclonal R anti-K (diluted 1 in 1300 in TBS) or R anti-) (diluted 1 in 1500 in TBS) for 30 minutes at room temperature, followed by an alkaline phosphatase-conjugated S anti-R (diluted 1 in 20 in TBS with 5% normal human AB serum) for 30 minutes. The alkaline phosphatase reaction was performed using the same substrate referred to above and, after a five minute wash with PBS, the Ki-67 immunoperoxidase staining was carried out. Slides were counterstained with haematoxylin for one minute and mounted with Glycergel. In the simultaneous procedure the reagents for the two sequences were mixed at each incubation step and all the incubations were carried out for 30 minutes. Normal mouse serum replaced Ki-67 in the negative control.
Ki-67 and anti-lysozyme To combine Ki-67 with the antibody R antiLys sequential or simultaneous double immunoenzymatic staining was performed ( fig   2) . In the sequential procedure the immunoperoxidase staining with Ki-67 was carried out first, and after a five minute wash with TBS cytospins were incubated with R anti-Lys (diluted 1 in 250 in TBS). The subsequent steps were carried out as described for the antilight chain antibodies. In the simultaneous procedure the reagents for the two sequences were mixed at each incubation step and all the incubations were carried out for 30 minutes. Normal rabbit serum was used instead of R anti-Lys as a negative control. (fig 3) .
Of the Ki-67 positive cells, 6-7% (range 3-9-16-5%) showed strong cytoplasmic reactivity with anti-K and 4-7% (range 2-7-13-4%) with anti-A. Of the Ki-67/K positive cells, 58%
(range 40-62%) were small and 42% (range 38-60%) medium sized. Of the Ki-67/2 positive cells, 46% (range 25-73%) were small and 54% (range 27-75%) medium sized. Both small and medium sized Ki-67 positive cells showed morphological features of lymphoplasmacytic cells, with a round slightly ecentric nucleus, abundant cytoplasm, and well developed Golgi zone that was more evident in the larger size cells (fig 4) .
All the cells showing cytoplasmic reactivity with anti-lysozyme (monocytes) were Ki-67 negative ( fig 5) . Half the Ki-67 positive cells could not be accounted for by the B and T cell markers used.
The cell morphology was always well preserved and showed good contrast between the nuclear brown reaction of Ki-67 and the cytoplasmic red staining of anti-CD3, anti-K, anti-) and anti-Lys. When the two primary antibodies used in the double staining were raised in different species, no cross-reactivity or differences of staining intensity were found when the reagents of each sandwich were applied simultaneously.
PERCENTAGE OF MATURE T AND B CELLS POSITIVE FOR KI-67
The percentages of T and B lymphocytes .:., a.
I & .4
group.bmj.com on July 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from chains of the second and third layers of the immunoperoxidase sandwich. This problem was solved by labelling the cells with the antilight chain antibodies first or at the same time as the Ki-67 staining. We did not observe crossreactivity when combining the two mouse monoclonal antibodies Ki-67 and UCHTI, as previously described. '3 Several authors have reported that the percentage of Ki-67 positive cells is an indicator of the biological behaviour of a tumour and therefore has important prognostic and therapeutic implications.2324 The demonstration that a proportion of normal blood cells are in cycle raises the issue of whether immunophenotypic analysis of the Ki-67 positive cells in haemopoetic malignancies with peripheral blood disease should always be carried out to define more precisely the proportion of normal and neoplastic cells in cycle.
